Externally Funded Projects
2017-2020: The Research Council of Norway. FRIMEDBIO program. Optimized activation of tumor-associated macrophages as a novel strategy for cancer immunotherapy
2018-2021: Helse Sør-Øst. A novel strategy for cancer vaccine based on optimized activation of dendritic cells. (Applicant: I. Øynebråten)
2019-2022 Norwegian Cancer Society. Using type I and type II interferons for cancer immunotherapy.
2019-2023 Helse Sør-Øst. Adoptive transfer of engineered macrophages, as a novel tool for cancer immunotherapy (Applicant: P. Christopoulos)
International Collaborations
- Institut Pasteur, Paris, France: V. Meas-Yedid, Jean-Christophe Olivo-Marin
- Biomedical Research and Study Centre, Riga, Latvia: Anna Zajakina
- Juntendo University School of Medicine, Tokyo, Japan: Hideo Jagita
- University of California, San Francisco (UCSF), USA: Lewis lanier